Ali I Fattom
Overview
Explore the profile of Ali I Fattom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sutter D, Summers A, Keys C, Taylor K, Frasch C, Braun L, et al.
FEMS Immunol Med Microbiol
. 2011 Jun;
63(1):16-24.
PMID: 21631600
Capsular polysaccharide (CP) plays an important role in the pathogenicity and immunogenicity of Staphylococcus aureus, yet the common serotypes of S. aureus isolated from US pediatric patients have not been...
2.
Melles D, Taylor K, Fattom A, van Belkum A
FEMS Immunol Med Microbiol
. 2008 Jan;
52(2):287-92.
PMID: 18218024
International epidemiological studies have shown that clinical isolates of Staphylococcus aureus are usually capsulated with either type 5 or 8 capsular polysaccharides (CPs). Because all noncapsulated strains were found to...
3.
von Eiff C, Taylor K, Mellmann A, Fattom A, Friedrich A, Peters G, et al.
Diagn Microbiol Infect Dis
. 2007 Mar;
58(3):297-302.
PMID: 17376630
Because of its ability to cause serious and fatal infections, Staphylococcus aureus remains one of the most feared microorganisms. Methicillin-resistant S. aureus (MRSA) has long been a common pathogen in...
4.
Verdier I, Durand G, Bes M, Taylor K, Lina G, Vandenesch F, et al.
J Clin Microbiol
. 2007 Jan;
45(3):725-9.
PMID: 17202275
Staphylococcus aureus is a major cause of nosocomial and community-acquired infections. The predominance of two capsular polysaccharides, types 5 and 8, on the surface of clinical isolates led to the...
5.
Fattom A, Horwith G, Fuller S, Propst M, Naso R
Vaccine
. 2004 Mar;
22(7):880-7.
PMID: 15040941
Staphylococcus aureus is the most common nosocomial pathogen and is responsible for approximately one-third of hospital-acquired bacteremias. The emergence of strains with multidrug resistance, including resistance to vancomycin, the antibiotic...
6.
Zhang N, Chen H, Koch V, Schmitz H, Minczuk M, Stepien P, et al.
J Med Chem
. 2003 Oct;
46(22):4776-89.
PMID: 14561097
A series of ring-expanded ("fat") nucleoside analogues (RENs) containing the 6-aminoimidazo[4,5-e][1,3]diazepine-4,8-dione ring system have been synthesized and screened for inhibition of NTPase/helicase of the West Nile Virus (WNV). To assess...
7.
Zhang N, Chen H, Koch V, Schmitz H, Liao C, Bretner M, et al.
J Med Chem
. 2003 Sep;
46(19):4149-64.
PMID: 12954067
A series of ring-expanded ("fat") heterocycles, nucleoside and nucleotide analogues (RENs) containing the imidazo[4,5-e][1,3]diazepine ring system (9, 14, 15, 18, 24-26, 28, 31, and 33) and imidazo[4,5-e][1,2,4]triazepine ring systems (30b,...
8.
Zhang N, Chen H, Sood R, Kalicharran K, Fattom A, Naso R, et al.
Bioorg Med Chem Lett
. 2002 Nov;
12(23):3391-4.
PMID: 12419368
The synthesis and in vitro anti-measles virus (anti-MV) activity of a class of ring-expanded ('fat') nucleoside analogues (1-4) containing the title heterocyclic ring system are reported. The target compounds were...
9.
Sood R, Bhadti V, Fattom A, Naso R, Korba B, Kern E, et al.
Antiviral Res
. 2001 Dec;
53(2):159-64.
PMID: 11750942
Novel ring-expanded nucleoside (REN) analogs (1-3) containing 5:7 fused ring systems as the heterocyclic base were found to be potent and selective inhibitors of hepatitis B virus (HBV) replication in...